SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Jemal A,Siegel R,Ward E,Murray T,Xu J,Thun MJ. Cancer statistics, 2007. CA Cancer Clin. 2007; 57: 4366.
  • 2
    U.S. Cancer Statistics Working Group. U.S. cancer statistics: 2004 incidence and mortality. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2007.
  • 3
    Dobrossy L. Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev. 2005; 24: 917.
  • 4
    Stambuk HE,Karimi S,Lee N,Patel SG. Oral cavity and oropharynx tumors. Radiol Clin North Am. 2007; 45: 120.
  • 5
    Blot WJ,McLaughlin JK,Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988; 48: 32823287.
  • 6
    Day GL,Blot WJ,Austin DF, et al. Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants. J Natl Cancer Inst. 1993; 85: 465473.
  • 7
    Furniss CS,McClean MD,Smith JF, et al. Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer. 2007; 120: 23862392.
  • 8
    Mashberg A,Boffetta P,Winkelman R,Garfinkel L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer. 1993; 72: 13691375.
  • 9
    Lingen M,Sturgis EM,Kies MS. Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for management. Curr Opin Oncol. 2001; 13: 176182.
  • 10
    Wiseman SM,Swede H,Stoler DL, et al. Squamous cell carcinoma of the head and neck in nonsmokers and nondrinkers: an analysis of clinicopatholgic characteristics and treatment outcomes. Ann Surg Oncol. 2003; 10: 551557.
  • 11
    Dahlstrand H,Dahlgren L,Lindquist D,Munck-Wikland E,Dalianis T. Presence of human papillomavirus in tonsillar cancer is a favourable prognostic factor for clinical outcome. Anticancer Res. 2004; 24: 18291835.
  • 12
    El-Mofty SK,Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2003; 27: 14631470.
  • 13
    Franceschi S,Munoz N,Bosch XF,Snijders PJ,Walboomers JM. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev. 1996; 5: 567575.
  • 14
    Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol. 2004; 31: 744754.
  • 15
    Herrero R,Castellsague X,Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003; 95: 17721783.
  • 16
    Klussmann JP,Weissenborn SJ,Wieland U, et al. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? Med Microbiol Immunol (Berl). 2003; 192: 129132.
  • 17
    McKaig RG,Baric RS,Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck. 1998; 20: 250265.
  • 18
    Mork J,Lie AK,Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001; 344: 11251231.
  • 19
    Ringstrom E,Peters E,Hasegawa M,Posner M,Liu M,Kelsey KT. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res. 2002; 8: 31873192.
  • 20
    Smith EM,Hoffman HT,Summersgill KS,Kirchner HL,Turek LP,Haugen TH. Human papillomavirus and risk of oral cancer. Laryngoscope. 1998; 108: 10981103.
  • 21
    Tran N,Rose BR,O'Brien CJ. Role of human papillomavirus in the etiology of head and neck cancer. Head Neck. 2007; 29: 6470.
  • 22
    Venuti A,Badaracco G,Rizzo C,Mafera B,Rahimi S,Vigili M. Presence of HPV in head and neck tumours: high prevalence in tonsillar localization. J Exp Clin Cancer Res. 2004; 23: 561566.
  • 23
    D'Souza G,Kreimer AR,Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356: 19441956.
  • 24
    Kreimer AR,Clifford GM,Boyle P,Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14: 467475.
  • 25
    Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol. 2005; 32( suppl 1): S59S66.
  • 26
    Chang F,Syrjanen S,Kellokoski J,Syrjanen K. Human papillomavirus (HPV) infections and their associations with oral disease. J Oral Pathol Med. 1991; 20: 305317.
  • 27
    Furrer VE,Benitez MB,Furnes M,Lanfranchi HE,Modesti NM. Biopsy vs. superficial scraping: detection of human papillomavirus 6, 11, 16, and 18 in potentially malignant and malignant oral lesions. J Oral Pathol Med. 2006; 35: 338344.
  • 28
    Miller CS. Herpes simplex virus and human papillomavirus infections of the oral cavity. Semin Dermatol. 1994; 13: 108117.
  • 29
    Smith EM,Ritchie JM,Summersgill KF, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst. 2004; 96: 449455.
  • 30
    Hobbs CG,Sterne JA,Bailey M,Heyderman RS,Birchall MA,Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006; 31: 259266.
  • 31
    Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol. 2004; 57: 449455.
  • 32
    Hankey BF,Ries LA,Edwards BK. The Surveillance, Epidemiology, and End Results Program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999; 8: 11171121.
  • 33
    Bradford CR,Zacks SE,Androphy EJ,Gregoire L,Lancaster WD,Carey TE. Human papillomavirus DNA sequences in cell lines derived from head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg. 1991; 104: 303310.
  • 34
    Fouret P,Monceaux G,Temam S,Lacourreye L,St Guily JL. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg. 1997; 123: 513516.
  • 35
    Ishibashi T,Matsushima S,Tsunokawa Y, et al. Human papillomavirus DNA in squamous cell carcinoma of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg. 1990; 116: 294298.
  • 36
    Watson M,Saraiya M,Ahmed F, et al. Using population-based cancer registry data to assess the burden of HPV-associated cancers in the US: overview of methods. Cancer. 2008; 113(10 suppl ): 28412854.
  • 37
    Surveillance Research Program. National Cancer Institute SEER-Stat Software, Version 6.1.4. Bethesda, MD: National Cancer Institute; 2005.
  • 38
    Surveillance, Epidemiology, and End Results Program. Summary staging guide for the Cancer Surveillance, Epidemiology, and End Results (SEER) Program. Bethesda, MD: National Institutes of Health, National Cancer Institute; 1977
  • 39
    Surveillance, Epidemiology, and End Results Program. Summary staging manual 2000. Bethesda, MD: National Institutes of Health, National Cancer Institute; 2005.
  • 40
    Howe HL,Jamison PM,Havener L,Chen VW,Ries LAG. Site-specific comparison of summary stage 1977 and summary stage 2000 coding. Available from URL: http://www.naaccr.org/index.asp?Col_SectionKey=11&Col_ContentID=397. Accessed on July 11, 2008.
  • 41
    PhillipsJL, ed. Summary stage: data effects of the changes in 2000. Available from URL: http://www.naaccr.org/filesystem/pdf/Summary%20Stage%20Report%201-21-04b.pdf. Accessed on July 11, 2008.
  • 42
    Department of Health and Human Services. Tobacco use among U.S. racial/ethnic minority groups—African-Americans, American-Indians and Alaska Natives, Asian-Americans and Pacific Islanders, and Hispanics: a report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 1998.
  • 43
    Greenberg RS,Haber MJ,Clark WS, et al. The relation of socioeconomic status to oral and pharyngeal cancer. Epidemiology. 1991; 2: 194200.
  • 44
    Kabat GC,Chang CJ,Wynder EL. The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer. Int J Epidemiol. 1994; 23: 11371144.
  • 45
    Chaturvedi AK,Engels EA,Anderson WF,Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the U.S. J Clin Oncol. 2008; 26: 612618.
  • 46
    Shiboski CH,Schmidt BL,Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer. 2005; 103: 18431849.
  • 47
    Davies L,Welch HG. Epidemiology of head and neck cancer in the U.S. Otolaryngol Head Neck Surg. 2006; 135: 451457.
  • 48
    Sturgis EM,Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007; 110: 14291435.
  • 49
    Parkin DM,Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine. 2006; 24( suppl 3): S11S25.
  • 50
    Mellin H,Dahlgren L,Munck-Wikland E, et al. Human papillomavirus type 16 is episomal, and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer. 2002; 102: 152158.